Opening the book…
Cause(s):
β globin chain amino acid substitution in the 6th position from glutamic acid (Glu) to lysine (Lys).1,2
Inheritance:
Autosomal dominant1
Demographics:
West Africa1
Clinical Features:1-3
See Hemoglobin C under RBC inclusions for additional information.
Less splenic sequestration and milder chronic hemolysis compared to sickle cell disease. Patients are usually asymptomatic.
Laboratory Features:1,2
|
CBC: Hb: Decreased Hct: Decreased |
PBS: Normochromic, normocytic RBCs *Hb C crystals Target cells nRBCs |
BM: N/A |
|
Hemoglobin Electrophoresis: Hb S: >90 Hb A: None Hb A2: Normal Hb F: <7% *Not always seen, more likely in patients who have had a splenectomy. |
Other Tests: Solubility Screen: Negative Metasulfite Sickling Test: Negative HPLC Hemoglobin Electrophoresis |
References:
1. Laudicina RJ. Hemoglobinopathies: qualitative defects. In: Clinical laboratory hematology. 3rd ed. New Jersey: Pearson; 2015. p.231–50.
2. Randolph TR. Hemoglobinopathies (structural defects in hemoglobin). In: Rodak’s hematology clinical applications and principles. 5th ed. St. Louis, Missouri: Saunders; 2015. p. 426-453.
3. Harmening DM, Yang D, Zeringer H. Hemolytic anemias: intracorpuscular defects. 5th ed. Philadelphia: F.A. Davis Company; 2009. p. 207-29).
This page titled 7.4: Hemoglobin C (Hb CC) Disease was last modified on Fri, 11 Sep 2026 16:40:04 GMT and is shared under a CC BY-NC 4.0 license and was authored, remixed, and/or curated by Valentin Villatoro and Michelle To (Open Education Alberta) via source content that was edited to the style and standards of the LibreTexts platform.
The book could not be loaded just now.